Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lauryl alcohol diphosphonic acid is a synthetic small molecule belonging to the bisphosphonate class of compounds. It contains two phosphonate groups attached to a lauryl (dodecyl) chain. Bisphosphonates are known for their ability to inhibit bone resorption by targeting enzymes involved in the mevalonate pathway. Specifically, lauryl alcohol diphosphonic acid acts as an inhibitor of farnesyl pyrophosphate synthase, an enzyme critical for osteoclast function and survival. This compound has not been approved for medical use and is primarily considered experimental; it has no reported clinical indications or approvals as a pharmaceutical agent[2]. It may also be used as an emulsion stabilizer in cosmetic formulations[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lauryl alcohol diphosphonic acid.